GlassScriptPhysician profile
Syed I Ali
NPI 1407838881
$1,711.36
in general payments reported to CMS, 2019-2025
21 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $16.66 · 2021: $334 · 2022: $339 · 2023: $213 · 2024: $242 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $406.39 | 2021-2024 | Turbohawk |
| Amgen INC. | $348.38 | 2019-2025 | Tepezza |
| Edwards Lifesciences Corporation | $164.01 | 2019-2023 | |
| Abbott Laboratories | $133.09 | 2021-2025 | Jot Dx |
| Astrazeneca Pharmaceuticals LP | $124.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $98.87 | 2023-2025 | |
| Abiomed | $83.23 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $58.63 | 2022-2023 | Verquvo, Steglatro |
| Tandem Diabetes Care, INC. | $56.12 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Averitas Pharma INC. | $34.17 | 2025 | Qutenza |
| Jazz Pharmaceuticals INC. | $26.34 | 2023 | |
| Pfizer INC. | $25.00 | 2022 | |
| Smith+Nephew, INC. | $22.47 | 2023 | Pico |
| Briohealth Solutions, INC. | $21.57 | 2025 | Briovad |
| Alnylam Pharmaceuticals INC. | $20.43 | 2023 | Onpattro |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascensia Diabetes Care US INC. | $19.32 | 2023 | |
| Cook Medical LLC | $17.22 | 2022 | |
| Kci USA, INC. | $14.59 | 2023 | Prevena |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.59 | 2025 | Lifevest |
| Boston Scientific Corporation | $11.55 | 2021 | |
| Novo Nordisk INC | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.